Yeshwanth Sankranthi1*, Ittedi Rajashekhar2, Ittedi Rani3
The emergence of SARS-COV2 from Wuhan at the end of December 2019 has spread to 200 countries is the leading cause of deaths. Belonging to be β-COV with single-strand RNA attacks the human respiratory system. The COVID-19 symptoms appear after incubation. The appearance of symptoms varies depending on the age and status of the immune system. Globally, current trials are on vaccines and focused on plasma therapy with the survivor’s plasma.